Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-31
2011-05-31
Saeed, Kamal A (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S187000, C546S270100, C544S135000
Reexamination Certificate
active
07951954
ABSTRACT:
The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta adrenoreceptor agonists.
REFERENCES:
patent: 2653977 (1953-09-01), Craig et al.
patent: 3775477 (1973-11-01), Diana
patent: 4460581 (1984-07-01), Schromm et al.
patent: 5648370 (1997-07-01), Bonnert et al.
patent: 6686353 (2004-02-01), Shiota et al.
patent: 7700782 (2010-04-01), Connolly et al.
patent: 7709511 (2010-05-01), Bonnert et al.
patent: 2002/0055651 (2002-05-01), Moran et al.
patent: 2003/0229058 (2003-12-01), Moran et al.
patent: 2006/0106075 (2006-05-01), Cuenoud et al.
patent: 2008/0207698 (2008-08-01), Connolly et al.
patent: 2008/0242649 (2008-10-01), Cadogan et al.
patent: 2008/0249145 (2008-10-01), Whittock et al.
patent: 2008/0300275 (2008-12-01), Bonnert et al.
patent: 2009/0029958 (2009-01-01), Alcaraz et al.
patent: 2009/0062259 (2009-03-01), Alcaraz et al.
patent: 2009/0203753 (2009-08-01), Bailey et al.
patent: 2009/0221653 (2009-09-01), Bailey et al.
patent: 2010/0022491 (2010-01-01), Connolly et al.
patent: 2010/0210688 (2010-08-01), Bonnert et al.
patent: 2010/0249200 (2010-09-01), Connolly et al.
patent: 0162576 (1985-11-01), None
patent: 0174811 (1986-03-01), None
patent: 0175525 (1986-03-01), None
patent: 0220878 (1987-05-01), None
patent: 0303466 (1989-02-01), None
patent: 0422889 (1991-04-01), None
patent: 2005-187357 (2005-07-01), None
patent: 7415945 (1975-06-01), None
patent: WO 92/08708 (1992-05-01), None
patent: WO 93/23385 (1993-11-01), None
patent: WO 93/24473 (1993-12-01), None
patent: WO 97/10227 (1997-03-01), None
patent: WO 97/23470 (1997-07-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 98/38180 (1998-09-01), None
patent: WO 98/45294 (1998-10-01), None
patent: WO 99/36095 (1999-07-01), None
patent: WO 99/64035 (1999-12-01), None
patent: WO 00/75114 (2000-12-01), None
patent: WO 01/11933 (2001-02-01), None
patent: WO 01/12167 (2001-02-01), None
patent: WO 01/12191 (2001-02-01), None
patent: WO 01/12192 (2001-02-01), None
patent: WO 01/42193 (2001-06-01), None
patent: WO 02/06255 (2002-01-01), None
patent: WO 02/076933 (2002-10-01), None
patent: WO 03/024439 (2003-03-01), None
patent: WO 2004/016578 (2004-02-01), None
patent: WO 2004/016601 (2004-02-01), None
patent: WO 2004/039766 (2004-05-01), None
patent: WO 2004/071388 (2004-08-01), None
patent: WO 2004/074276 (2004-09-01), None
patent: WO 2004/089892 (2004-10-01), None
patent: WO 2005/030678 (2005-04-01), None
patent: WO 2005/040103 (2005-05-01), None
patent: WO 2005/044787 (2005-05-01), None
patent: WO 2005/070872 (2005-08-01), None
patent: WO 2005/074924 (2005-08-01), None
patent: WO 2005/092841 (2005-10-01), None
patent: WO 2005/092861 (2005-10-01), None
patent: WO 2005/092870 (2005-10-01), None
patent: WO 2005/110990 (2005-11-01), None
patent: WO 2005/111002 (2005-11-01), None
patent: WO 2005/111004 (2005-11-01), None
patent: WO 2005/121065 (2005-12-01), None
patent: WO 2006/014704 (2006-02-01), None
patent: WO 2006/023457 (2006-03-01), None
patent: WO 2006/023460 (2006-03-01), None
patent: WO 2006/031556 (2006-03-01), None
patent: WO 2006/056471 (2006-06-01), None
patent: WO 2006/074897 (2006-07-01), None
patent: WO 2006/128675 (2006-12-01), None
patent: WO 2007/010356 (2007-01-01), None
patent: WO 2007/018461 (2007-02-01), None
patent: WO 2007/027133 (2007-03-01), None
patent: WO 2007/027134 (2007-03-01), None
patent: WO 2007/102771 (2007-09-01), None
patent: WO 2007/106016 (2007-09-01), None
patent: WO 2008/041914 (2008-04-01), None
patent: WO 2008/075025 (2008-06-01), None
patent: WO 2008/075026 (2008-06-01), None
patent: WO 2008/096111 (2008-08-01), None
patent: WO 2008/096112 (2008-08-01), None
patent: WO 2008/096119 (2008-08-01), None
patent: WO 2008/096121 (2008-08-01), None
patent: WO 2008/104776 (2008-09-01), None
patent: WO 2008/104790 (2008-09-01), None
patent: WO 2009/037503 (2009-03-01), None
Austin et al. “QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists” J. Med. Chem. 2003 46:3210-3220.
Berge et al. “Pharmaceutical Salts” J Pharmaceutical Sciences. 1977 66(1) 1-19.
Bonnert et al. “Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)-4-hydroxybenzothiazol-2(3H)-one Analogues” J. Med Chem. 1998 (41) 4915-4917.
Davies et al. “Indacaterol. Asthma therapy Treatment of COPD β2-Adrenoceptor Agonist” Drugs of the Future. 2005 30(12) 1219-1224.
Dougall et al. “Dual dopamine D2receptor and β2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale” Respir Med (Suppl A). 2003 (97) S3-S7 (Abstract).
Fernandez et al. “Alkaline Hydrolysis of 1,2,3-Trisubstituted Cyclic Amidinium Salts. Kinetic Study of N 4 N′ Acyl Migration in Alkaline Solution in an Ethylenediamine Derivative” J.C.S. Perkin II. 1978 545-550.
Fernandez et al. “N 4 N′ Intramolecular Acyl Transfer in Acid Media for Alkylenediamine Derivatives” J.C.S. Perkin II. 1978 550-553.
Horig et al. “From bench to clinic and back: Perspective on the 1stIQPC Translational Research conference” Journal of Translational Medicine. 2004 2(44) 1-8.
Johnson “Beta2-adrenoceptors: mechanisms of action of beta2-agonists” Paediatric Respiratory Reviews. 2001 (2) 57-62.
Norman, “Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119” Expert Opin. Ther. Patents. 2009 19(7) 1-7.
Schäfer et al. “Failure is an option: learning from unsuccessful proof-of-concept trials” Drug Discovery Today. 2008 13(21/22) 913-916.
Weinstock et al. “Synthesis and Evaluation of Non-Catechol D-1 and D-2 Dopamine Receptor Agonists: Benzimidazol-2-one, Benzoxazol-2-one, and the Highly Potent Benzothiazol-2-one 7 Ethylamines” J Med Chem. 1987 (30) 1166-1176.
Wermuth et al., Handbook of Pharmaceutical salts: properties, selection and use, (2002) pp. 1-7: published by Wiley-VCH Verlag, ISBN: 10-3-906390-26-8.
Wright et al. “The Rearrangement ofN-(Methylamino-alkyl)anilides” J Org Chem. 1961 26(6) 2120-2123.
USPTO Non-Final Office Action in U.S. Appl. No. 11/959,679, mailed Feb. 25, 2009, 12 pages.
Fish & Richardson P.C., Amendment in Reply to Action of Feb. 25, 2009 in U.S. Appl. No. 11/959,679, filed Jul. 15, 2009, 6 pages.
USPTO Notice of Allowance in U.S. Appl. No. 11/959,679, mailed Nov. 9, 2009, 9 pages.
Fish & Richardson P.C., Response to Notice of Allowance mailed Nov. 9, 2009 in U.S. Appl. No. 11/959,679, filed Feb. 9, 2009, 2 pages.
USPTO Notice of Allowance in U.S. Appl. No. 12/063,322, mailed Feb. 26, 2010, 12 pages.
Fish & Richardson P.C., Response to Notice of Allowance mailed Feb. 26, 2010 in U.S. Appl. No. 12/063,322, filed Mar. 5, 2010, 2 pages.
USPTO Non-Final Office Action in U.S. Appl. No. 12/069,180, mailed Feb. 3, 2010, 19 pages.
Fish & Richardson P.C., Amendment in Replay to Action of Feb. 3, 2010 in U.S. Appl. No. 12/069,180, filed Aug. 6, 2010, 8 pages.
USPTO Non-Final Office Action in U.S. Appl. No. 12/069,180, mailed Oct. 15, 2010, 19 pages.
USPTO Notice of Allowance in U.S. Appl. No. 12/065,160, mailed Jun. 15, 2010, 9 pages.
Fish and Richardson P.C., RCE/IDS in response to Notice of Allowance mailed Jun. 15, 2010 in U.S. Appl. No. 12/065,160, filed Sep. 15, 2010, 9 pages.
Swedish Search Report for Application No. PCT/SE2006/000927, dated Oct. 27, 2006, 8 pages.
European Search Report for Application No. PCT/GB2007/004861, dated Mar. 28, 2008, 4 pages.
Alcaraz Lilian
Lister Andrew
Pairaudeau Garry
Astrazeneca AB
Fish & Richardson P.C.
Grazier Nyeemah
Saeed Kamal A
LandOfFree
Bezothiazol derivatives as Beta2 adrenoreceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bezothiazol derivatives as Beta2 adrenoreceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bezothiazol derivatives as Beta2 adrenoreceptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2668278